Publications by authors named "Han Koo"

Claim this Profile
A
Anti-proteolytic regulation of KRAS by USP9X/NDRG3 in KRAS-driven cancer development.
Han Koo, Kyung Chan Park, Hyun Ahm Sohn, Minho Kang, Dong Joon Kim

Nat Commun· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM promotes invasiveness of adjacent and lung cancer cells.
Seong-Lan Yu, Han Koo, Yujin Kang, Hye Jin Jeon, Minho Kang

Toxicol Lett· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity.
Chang Ryul Park, Minhyeok Lee, Su Yel Lee, Daeun Kang, Se Jin Park, Han Koo

Noncoding RNA Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycogen Storage Disease Phenotypes Accompanying the Perturbation of the Methionine Cycle in NDRG3-Deficient Mouse Livers.
Hyun Ahm Sohn, Dong Chul Lee, Anna Park, Minho Kang, Byoung-Ha Yoon, Han Koo

Cells· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LPIN1 Induces Gefitinib Resistance in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer Cells.
Jung Hee Cho, Yeon-Mi You, Han Koo, Dong Chul Lee, Young Il Yeom

Cancers (Basel)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PKM2 Regulates HSP90-Mediated Stability of the IGF-1R Precursor Protein and Promotes Cancer Cell Survival during Hypoxia.
Han Koo, Sangwon Byun, Jieun Seo, Yuri Jung, Dong Chul Lee

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Synthetic CPP33-Conjugated Active Domain Peptide Inhibits Invasion Ability of Non-Small Lung Cancer Cells.
Seong-Lan Yu, Han Koo, Se-In Lee, JaeKu Kang, Young-Hyun Han

Biomolecules· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant cell-permeable HOXA9 protein inhibits NSCLC cell migration and invasion.
Seong-Lan Yu, Han Koo, Hoi Young Lee, Young Il Yeom, Dong Chul Lee

Cell Oncol (Dordr)· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth.
Young Soo Park, Dong Joon Kim, Han Koo, Se Hwan Jang, Yeon-Mi You

Oncotarget· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyruvate kinase isoenzyme M2 is a therapeutic target of gemcitabine-resistant pancreatic cancer cells.
Dong Joon Kim, Young Soo Park, Min Gu Kang, Yeon-Mi You, Yuri Jung, Han Koo

Exp Cell Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel pyruvate kinase M2 activator compound that suppresses lung cancer cell viability under hypoxia.
Dong Joon Kim, Young Soo Park, Nam Doo Kim, Sang Hyun Min, Yeon-Mi You, Han Koo

Mol Cells· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis